Author Archives: admin

A Risperdal Case Study

Mad in America, a group focused on re-examining mental health treatment, recently posted the following article that recounts one family’s experience with antipsychotic drug use in a nursing home. While this happened in 2009, before the recent federal and state … Continue reading

Share

Britain Shows the Way for Antipsychotic Reduction

by Michael Connors, CANHR Advocate According to a new report by the British government, the number of people with dementia who are being given antipsychotics dropped by more than half (52 percent) between 2008 and 2011. The remarkable findings are … Continue reading

Share

McKnight’s Shameful Blog Post

by Anthony Chicotel, CANHR Staff Attorney McKnight’s, a magazine and provider of long-term care news and commentary, recently posted a Daily Editor’s Blog article from John O’Connor, decrying the increased federal focus on the misuse of antipsychotics as a front-line … Continue reading

Share

CMS Flip-Flops on Independent Pharmacist Requirements

by Michael Connors, Advocate With great support from CANHR and many other advocates, CMS published regulations in October 2011 proposing to require nursing home consultant pharmacists to be independent from long term care pharmacies. CMS then explained that new requirements … Continue reading

Share

Alive Inside

By Michael Connors, CANHR Advocate Hard to believe but true, Henry Dreher, a 94 year-old nursing home resident, is the latest internet sensation. Until recently, Henry was increasingly withdrawn and communicated little in the nursing home memory care unit where … Continue reading

Share

Medi-Cal Restricts Payments for Antipsychotic Drugs in Nursing Homes

by Michael Connors, CANHR Advocate On October 1, 2011, Medi-Cal implemented a little-publicized new policy requiring skilled nursing facilities to jump through new hoops before Medi-Cal will pay for the use of antipsychotic drugs prescribed for residents. The policy establishes … Continue reading

Share

CMS to Introduce Campaign to Reduce Antipsychotic Use on March 29

by Michael Connors, CANHR Advocate The Centers for Medicare and Medicaid Services (CMS) has announced that it is developing a national action plan to protect nursing home residents from unnecessary antipsychotic drug use and to improve dementia care. CMS is … Continue reading

Share

Study Says Haldol Even More Deadly than Other Antipsychotics

by Michael Connors, CANHR Advocate A Harvard Medical School study published in the British Medical Journal (BMJ) on February 23, 2012 reports that U.S. nursing home residents who took Haldol had double the risk of death as those who took … Continue reading

Share

Least Medicating Movement Going Viral

by Mike Connors, CANHR Advocate Congressional hearings sometimes come and go with little effect, but November’s U.S. Senate Special Committee on Aging hearing on the misuse of antipsychotic drugs in nursing homes is giving a major boost to the least … Continue reading

Share

Independent Pharmacists Needed to Review Residents’ Drugs

Looking to help protect nursing home residents from chemical restraints? There is a great, easy opportunity to do so this week, courtesy of the National Consumer Voice for Quality Long Term Care. In response to proposed federal regulations that would … Continue reading

Share